Table 3. Results of univariate analysis of very early (<1yr) and early (<2yr) recurrence.
| Variable | Recurrence @ 1 year | N | P |
|---|---|---|---|
| Anatomic resection | 10% | 76 | 0.019 |
| Non-anatomic resection | 26% | 56 | |
| Tumor size <15mm | 12% | 27 | 0.002 |
| Tumor size ≥ 15mm | 35% | 105 | |
| Margin <10mm | 24% | 36 | 0.023 |
| Margin ≥ 10mm | 4% | 47 | |
| Satellites present | 45% | 16 | 0.002 |
| Satellites absent | 12% | 116 | |
| Very early tumors (BCLC 0/Japanese T1) | 12% | 85 | 0.029 |
| Others (BCLC A/Japanese T2) | 27% | 47 | |
| Recurrence @ 2 year | |||
| Tumor size <15mm | 27% | 27 | 0.017 |
| Tumor size ≥ 15mm | 49% | 105 | |
| Satellites present | 62% | 16 | 0.003 |
| Satellites absent | 28% | 116 | |
| Poor differentiation | 57% | 21 | 0.034 |
| Moderate or Well | 28% | 104 | |
| Fibrosis (0-3)* | 25% | 38 | 0.019 |
| Cirrhosis (Fibrosis 4)* | 42% | 89 |
*
Metavir fibrosis score